HOME | NEWSROOM | CONTACT US | SEARCH
 
Cellectar | Company
Cellectar | The Science
Cellectar | Clinical Trials
Cellectar | Development & Manufacturing
Return...

Scientific Advisors

Richard Wahl, M.D., Dr. Wahl is a leading expert in positron emission tomography (PET).  He is currently on the faculty of Johns Hopkins University as Director of the Division of Nuclear Medicine, Director of the PET Center, and Vice-Chair for Technology and New Business Development within the Russell H. Morgan Department of Radiology and Radiological Services.  Dr. Wahl has received numerous national and international awards in oncologic imaging and therapy research.  He was also instrumental in the development and commercialization of Bexxar, an 131I radiolabeled monoclonal antibody for non-hodgkins lymphoma.

Joanne Mortimer, M.D. FACP., Dr. Mortimer is the Vice Chair for Medical Oncology at the City of Hope. She is also Associate Director for Affiliate Programs and the Administrative Director for Phase I Programs. Dr. Mortimer has participated in clinical trials in Breast Cancer research for over 25 years. Her research has focused on assessing the effects of systemic therapies on cancer and normal tissues. Previously, Dr. Mortimer was the Deputy Director of Medical Oncology at Moores Cancer Center at the University of California, San Diego, Medical Director of the Sentara Cancer Institute, Head of Hematology and Medical Oncology and Professor of Internal Medicine at the Eastern Virginia Medical School, Director of Clinical Oncology and Professor of Medicine at the Washington University School of Medicine in St. Louis, Associate of Clinical Research at the Fred Hutchinson Cancer Center in Seattle, and Assistant Professor at the University of Washington's School of Medicine. Dr. Mortimer is currently a consulting member of the Oncologic Drug Advisory Committee of the U.S. Food and Drug Administration.

©Cellectar, LLC | All Rights Reserved | info@cellectar.com | Site Credit
 
Search Button